We further analyzed CD47 IHC changes in patients who had matched tissue available from TURBT and RC samples; as a result, patients who underwent a complete pathologic response with no tumor identified on RC were not studied due to a lack of post-treatment tumor. The gene discussed is CD47; the disease is neoplasm.